Worldwide Clinical Trials is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology companies. The company offers end-to-end solutions, including early and late phase clinical trials, bioanalytical laboratory services, data management, and consulting across various therapeutic areas such as oncology, neuroscience, and rare diseases.
Subscribe to see Worldwide Clinical Trials' Early Phase’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Worldwide Clinical Trials' Early Phase is a biotech company headquartered in United States. Xcout tracks 72 named people at Worldwide Clinical Trials' Early Phase, including Alistair Macdonald (Chief Executive Officer). Xcout recorded 194 job postings from Worldwide Clinical Trials' Early Phase in the last 90 days, naming tools such as Salesforce, Workday, Power BI.
66 more named people on record for Worldwide Clinical Trials' Early Phase, with roles, board committees and tenure — see the full roster →
Xcout recorded 194 job postings from Worldwide Clinical Trials' Early Phase in the last 90 days, from a hiring record Xcout has kept since September 2026.
The weekly hiring trend, the roles and locations behind it — see Worldwide Clinical Trials' Early Phase's hiring signals →
Based on 119 job postings in the last 8 weeks (10 Aug – 4 Oct 2026), compared with 168 enterprise healthcare companies.
This describes a hiring pattern — how often Worldwide Clinical Trials' Early Phase’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
A few of Worldwide Clinical Trials' Early Phase's closest competitors — see the full list of competitors and alternatives →
Celerion operates as an early-phase clinical research contract research organization (CRO) providing bioanalytical sciences, drug development, and regulatory services to pharmaceutical and biotechnology companies. The company conducts early-phase clinical trials, pharmacokinetic and pharmacodynamic analysis, immunogenicity testing, and biomarker analysis to accelerate drug development processes.
Weitao Biotech (operating as IQVIA Biotech) functions as a specialized, full-service contract research organization (CRO) supporting biotech and biopharmaceutical companies globally. It provides clinical development solutions and therapeutic expertise across various fields, including oncology, cell and gene therapy, central nervous system studies, cardiovascular, renal and metabolic diseases, dermatology, and internal medicine.
WuXi Biology provides a comprehensive spectrum of preclinical biology services and solutions for drug discovery, supporting clients from target discovery and validation to hit finding, lead optimization, and candidate selection. The company offers specialized platforms and expertise across major disease areas and therapeutic modalities, including small molecules, oligonucleotides, peptides, and antibodies.
Viroclinics Biosciences is a Netherlands-based contract research organization specializing in virology and infectious-disease research. It serves pharmaceutical and biotechnology companies by providing preclinical and clinical virology services, including antiviral and vaccine development support, viral diagnostics, and related laboratory testing.
Vivo Bio Tech Limited is an India-based contract research organization that provides preclinical drug-discovery and development services, including in-vivo pharmacology, toxicology, and related bioanalytical work. It serves pharmaceutical and biotechnology companies developing drugs and other healthcare products.
TFS HealthScience is a global contract research organization (CRO) with its global headquarters in Lund, Sweden, and additional major operations in the United States. The company partners with pharmaceutical and biotechnology firms to conduct clinical trials and drug development.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.